Technology | Quality Assurance (QA) | April 27, 2018

Sun Nuclear Launches SunCheck 2.0

Complete platform enables integrated, independent quality assurance in radiation

Designed to support a broad range of planning and delivery technologies, SunCheck 2.0 streamlines and standardizes workflows, allowing greater overall focus on patient safety.

April 27, 2018 — Sun Nuclear Corp. released significant new functionality for its SunCheck Platform for patient and machine quality assurance (QA) in radiation therapy. Designed to support a broad range of planning and delivery technologies, SunCheck 2.0 streamlines and standardizes workflows, allowing greater overall focus on patient safety.  

With SunCheck, hospitals and cancer centers gain:

  • One solution for radiation therapy QA. Managing all patient and machine QA in a consistent way helps reduce the likelihood of errors going undetected;
  • Speed and efficiency through automation. Less time spent on manual tasks means more bandwidth for data analysis, clinical decisions and continuous improvement; and
  • Access from anywhere. SunCHECK is browser-based and accessible to staff through a secure network. From dashboard reviews to deep data analysis, a single database drives the entire process.

Within the SunCheck Platform, SunCheck Patient integrates all phases of patient QA into a seamless workflow, including secondary checks, phantomless pre-treatment QA and in-vivo monitoring.

Key new functionality includes:

  • EPID-based Transit Dosimetry, compliant with 2013/59/EURATOM, Article 83;
  • Pre-set, yet customizable, dose tolerances per phase, with Universal Metrics; and
  • Expanded 3-D secondary dose and MU calculation support, including for TomoTherapy (Monte Carlo-based), high dose rate (HDR) brachytherapy and stereotactic cone systems.

SunCheck Machine helps to improve standardization and ease compliance reporting for daily, monthly and annual QA across locations, machines and staff.

Key new functionality includes:

  • Standard and complete TG-142 templates;
  • User-friendly editing or creation of customized QA templates and tasks;
  • Direct device connectivity to Sun Nuclear’s Daily QA 3 and IC Profiler solutions; and
  • Centralized data storage and flexible reporting for accreditation and compliance.

SunCheck 2.0 featured in the Sun Nuclear booth at the 2018 European Society for Radiotherapy and Oncology Congress (ESTRO 37), April 20-24 in Barcelona, Spain.

For more information: www.sunnuclear.com

 

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...